tiprankstipranks
Capha Pharmaceuticals Inc. (FPSUF)
OTHER OTC:FPSUF
US Market

Capha Pharmaceuticals (FPSUF) Financial Statements

1 Followers

Capha Pharmaceuticals Financial Overview

Capha Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is -12.50; Capha Pharmaceuticals is scheduled to report earnings on August 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -52.41KC$ -32.21KC$ -17.63KC$ 19.48KC$ -58.13K
EBITDAC$ -52.36KC$ -32.16KC$ -17.59KC$ 19.55K-
Net Income Common StockholdersC$ -52.41KC$ -32.21KC$ -17.63KC$ 19.48KC$ -58.13K
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 1.92KC$ 1.90KC$ 837.00C$ 1.03KC$ 318.00
Total AssetsC$ 3.03KC$ 3.58KC$ 1.74KC$ 2.26KC$ 1.75K
Total DebtC$ 462.07KC$ 450.57KC$ 425.07KC$ 416.07KC$ 391.07K
Net DebtC$ 460.15KC$ 448.67KC$ 424.23KC$ 415.04KC$ 390.75K
Total LiabilitiesC$ 483.16KC$ 463.51KC$ 447.09KC$ 429.98KC$ 411.69K
Stockholders EquityC$ -480.13KC$ -459.93KC$ -445.35KC$ -427.72KC$ -409.94K
Cash Flow-
Free Cash FlowC$ -11.47KC$ -24.44KC$ -9.19KC$ -24.29KC$ -55.76K
Operating Cash FlowC$ -11.47KC$ -24.44KC$ -9.19KC$ -24.29KC$ -55.76K
Investing Cash Flow-----
Financing Cash FlowC$ 11.50KC$ 25.50KC$ 9.00KC$ 25.00KC$ 53.00K
Currency in CAD

Capha Pharmaceuticals Earnings and Revenue History

Capha Pharmaceuticals Debt to Assets

Capha Pharmaceuticals Cash Flow

Capha Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis